Excellent post. That is why I am keeping my feet on the ground and will patiently await the forthcoming known fundamentals inflection points to be reached, before getting too excited.
Hopefully they will all meet reasonable expectations and (again hopefully) there will be no TO offer accepted before then, as any such offer will not meet what would be achieved once the 4 P2 results are known and positive. Of course, this pathway involves unknown risk, but if ever there was a stock to undertake risk with, then Neuren is it (IMO).
Further, should we achieve continued Daybue success, and 4 positive 2591 P2 trials I hope that Neuren will continue as an independent entity and become a great Australian success story. It is not beyond the bounds of possibility that our competent management could achieve a prudent strategy to enable this to become a reality, if all the pieces fall into place along the journey.
Whatever, the exciting times ahead will undoubtedly involve SP gyrations, the market will see to that. Perhaps, best not to focus too much on paper profits at this stage, because although they are exciting, the reverse is hard to stomach. Therefore, for those in for the longer term, best to keep the eyes firmly fixed on the chosen exit point, but always bearing in mind the risk that longer term multi-bagging dreams entail.
NEU Price at posting:
$24.04 Sentiment: Hold Disclosure: Held
(20min delay)
